In a patient with 5 days of frequent diarrhea, positive fecal leukocytes and occult blood, and negative Clostridioides difficile test and routine stool cultures, what is the most appropriate next step in management?

Proceed with flexible sigmoidoscopy to evaluate for inflammatory bowel disease

Given the presence of fecal leukocytes and occult blood with negative C. difficile and routine cultures, you should perform flexible sigmoidoscopy to assess for inflammatory bowel disease (IBD) or other mucosal pathology. This patient's clinical picture—5 days of inflammatory diarrhea (evidenced by fecal leukocytes and occult blood) with negative initial testing—warrants direct visualization of the colonic mucosa.

Diagnostic Approach

Why Endoscopy is Indicated

The 2017 IDSA guidelines specifically recommend stool testing for Salmonella, Shigella, Campylobacter, Yersinia, C. difficile, and STEC in patients with fever, bloody or mucoid stools, severe cramping, or signs of sepsis 1. However, when these initial tests are negative despite inflammatory markers (fecal leukocytes and occult blood), the differential broadens significantly.

The British Society of Gastroenterology guidelines for acute severe colitis explicitly state that patients presenting with possible acute severe colitis should undergo flexible sigmoidoscopy to confirm diagnosis and obtain histology 2. While this patient may not meet full criteria for acute severe UC, the inflammatory nature of the diarrhea (fecal leukocytes + occult blood) persisting for 5 days warrants endoscopic evaluation.

Additional Testing to Consider Before or Alongside Endoscopy

Expand your stool pathogen testing:

• Yersinia enterocolitica if there is abdominal pain, particularly right lower quadrant pain 1
• Vibrio species if there's exposure to brackish water or raw shellfish 1
• Parasitic evaluation including Cryptosporidium, Cyclospora, Cystoisospora, and Entamoeba histolytica
• Viral studies (norovirus, rotavirus) particularly if there's an outbreak context 3

Recent research demonstrates that among hospitalized patients with negative C. difficile testing and persistent diarrhea, alternative infectious causes (norovirus, rotavirus, enteropathogenic E. coli, Salmonella) were identified in 13% using multiplex PCR panels 3. This supports broader pathogen testing in your patient.

What Endoscopy Will Reveal

Flexible sigmoidoscopy with biopsies will help differentiate:

• IBD (ulcerative colitis or Crohn's disease): Look for continuous inflammation, ulceration, friability, and obtain biopsies for histology
• Cytomegalovirus (CMV) colitis: Particularly important in immunocompromised patients; requires tissue biopsy with immunohistochemistry 2
• Ischemic colitis: Segmental distribution, often in watershed areas
• Pseudomembranous colitis: Though C. difficile testing is negative, false negatives occur in 9-21% after first test 4. Endoscopy revealing pseudomembranes would confirm C. difficile disease despite negative toxin assays 5

Important Caveats

C. difficile Testing Limitations

While your patient has negative C. difficile testing, be aware that:

• First stool specimen has only 79% sensitivity; second specimen increases cumulative sensitivity to 91% 4
• In rare cases with high clinical suspicion, colonoscopy may reveal pseudomembranous colitis despite negative toxin tests 5
• However, do not repeat C. difficile testing unless symptoms persist after appropriate treatment or new symptoms develop 6

Fecal Leukocytes and Occult Blood Interpretation

The presence of both fecal leukocytes and occult blood increases the likelihood of invasive bacterial pathogens, but these tests have limited specificity. In one pediatric study, only 70% of Shigella cases had fecal leukocytes, and agreement between positive fecal leukocytes and occult blood was poor 7. The combination of dysentery with both tests positive was associated with invasive agents in 88% of cases 7.

If Immunocompromised

If your patient is immunocompromised, the IDSA guidelines recommend a broader differential including Cryptosporidium, Cyclospora, Cystoisospora, microsporidia, Mycobacterium avium complex, and CMV 1. This would make endoscopy with biopsies even more critical.

Clinical Algorithm

1. Obtain additional stool testing for expanded bacterial pathogens (Yersinia, Vibrio if indicated), parasites, and consider multiplex PCR panel
2. Perform flexible sigmoidoscopy with biopsies to evaluate for:
   • IBD (obtain biopsies from inflamed and normal-appearing mucosa)
   • CMV (if immunocompromised or severe inflammation)
   • Other mucosal pathology
3. If endoscopy reveals IBD, initiate appropriate IBD-directed therapy while continuing to treat any identified infections
4. If all testing remains negative, consider non-infectious causes including medication-induced colitis, microscopic colitis (requires biopsies), or disrupted gastrointestinal microbiota 3

The key is that inflammatory diarrhea (fecal leukocytes + occult blood) persisting 5 days with negative routine testing requires direct mucosal visualization to guide definitive management and avoid missing treatable conditions like IBD or opportunistic infections.